BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15693745)

  • 1. Treatment options for bipolar depression.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 1():3-6. PubMed ID: 15693745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice. Bipolar disorder--a focus on depression.
    Frye MA
    N Engl J Med; 2011 Jan; 364(1):51-9. PubMed ID: 21208108
    [No Abstract]   [Full Text] [Related]  

  • 3. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine/fluoxetine combination for bipolar depression.
    Shelton RC
    Expert Rev Neurother; 2006 Jan; 6(1):33-9. PubMed ID: 16466309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study.
    Pan PY; Lee MS; Lo MC; Yang EL; Yeh CB
    BMC Psychiatry; 2014 May; 14():145. PubMed ID: 24885966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bipolar depression: management options.
    Malhi GS; Mitchell PB; Salim S
    CNS Drugs; 2003; 17(1):9-25. PubMed ID: 12467490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of FDA-approved treatment options in bipolar depression.
    McIntyre RS; Cha DS; Kim RD; Mansur RB
    CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
    Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer treatment studies for bipolar depression.
    Gao K; Calabrese JR
    Bipolar Disord; 2005; 7 Suppl 5():13-23. PubMed ID: 16225556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar disorder: an update.
    El-Mallakh RS; Elmaadawi AZ; Loganathan M; Lohano K; Gao Y
    Postgrad Med; 2010 Jul; 122(4):24-31. PubMed ID: 20675968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bipolar depression: an update.
    Fountoulakis KN; Grunze H; Panagiotidis P; Kaprinis G
    J Affect Disord; 2008 Jul; 109(1-2):21-34. PubMed ID: 18037498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-resistant bipolar disorder.
    Gitlin M
    Mol Psychiatry; 2006 Mar; 11(3):227-40. PubMed ID: 16432528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
    Calabrese JR; Elhaj O; Gajwani P; Gao K
    J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical inquiries: what drugs are best for bipolar depression?
    Ukaegbu C; Banks JB; Carter NJ; Goldman LS
    J Fam Pract; 2008 Sep; 57(9):606-8. PubMed ID: 18786334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S;
    Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
    Yatham LN
    J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
    Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
    J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.